Personal Initiative. Dynamic Pace. Meaningful Work.
Novo Holdings Completes Acquisition of Catalent
Catalent to Strengthen Leading Position as a Global Service Provider for the Pharma and Biotech Industry under Private Ownership
Catalent, a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a global life sciences investment firm announced that Novo Holdings has completed its previously announced acquisition of Catalent.
Who We AreCatalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives.
We Are GlobalWith sites throughout North America, Europe, Latin America and Asia Pacific, there are endless opportunities for growth, development and global exposure. Connect with our global network across multiple continents today!
Our diverse team works together in support of our mission to help people live better, healthier lives. If you want the opportunity to take personal initiative, work at a dynamic pace and positively impact the lives of millions of people across the globe, join us!
Catalent fosters an environment in which individuals are respected, where differences and similarities are valued, and where everyone has opportunities to succeed. We strive to build a diverse and inclusive workplace.
At Catalent, responsibility and sustainability are integrated into the heart of our business. We have a global network of over 45 community ambassadors who organize various fundraisers and volunteer events throughout the year.